These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 29198132)
1. MEG3 long non-coding RNA prevents cell growth and metastasis of osteosarcoma. Zhang SZ; Cai L; Li B Bratisl Lek Listy; 2017; 118(10):632-636. PubMed ID: 29198132 [TBL] [Abstract][Full Text] [Related]
2. LncRNA-MEG3 inhibits cell proliferation of endometrial carcinoma by repressing Notch signaling. Guo Q; Qian Z; Yan D; Li L; Huang L Biomed Pharmacother; 2016 Aug; 82():589-94. PubMed ID: 27470401 [TBL] [Abstract][Full Text] [Related]
3. LncRNA MEG3 negatively modified osteosarcoma development through regulation of miR-361-5p and FoxM1. Shen B; Zhou N; Hu T; Zhao W; Wu D; Wang S J Cell Physiol; 2019 Aug; 234(8):13464-13480. PubMed ID: 30624782 [TBL] [Abstract][Full Text] [Related]
4. Knockdown of lncRNA MEG3 inhibits viability, migration, and invasion and promotes apoptosis by sponging miR-127 in osteosarcoma cell. Wang Y; Kong D J Cell Biochem; 2018 Jan; 119(1):669-679. PubMed ID: 28636101 [TBL] [Abstract][Full Text] [Related]
5. Long Noncoding RNA EWSAT1 Promotes Osteosarcoma Cell Growth and Metastasis Through Suppression of MEG3 Expression. Sun L; Yang C; Xu J; Feng Y; Wang L; Cui T DNA Cell Biol; 2016 Dec; 35(12):812-818. PubMed ID: 27860482 [TBL] [Abstract][Full Text] [Related]
6. LncRNA, CRNDE promotes osteosarcoma cell proliferation, invasion and migration by regulating Notch1 signaling and epithelial-mesenchymal transition. Li Z; Tang Y; Xing W; Dong W; Wang Z Exp Mol Pathol; 2018 Feb; 104(1):19-25. PubMed ID: 29246789 [TBL] [Abstract][Full Text] [Related]
7. Downregulation of lncRNA SNHG12 reversed IGF1R-induced osteosarcoma metastasis and proliferation by targeting miR-195-5p. Xu N; Xu J; Zuo Z; Liu Y; Yan F; Han C Gene; 2020 Feb; 726():144145. PubMed ID: 31743769 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of miR-664a interferes with the migration of osteosarcoma cells via modulation of MEG3. Sahin Y; Altan Z; Arman K; Bozgeyik E; Koruk Ozer M; Arslan A Biochem Biophys Res Commun; 2017 Aug; 490(3):1100-1105. PubMed ID: 28669734 [TBL] [Abstract][Full Text] [Related]
9. Effect of lncRNA LET on proliferation and invasion of osteosarcoma cells. Kong G; Qi XJ; Wang JF Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1609-1614. PubMed ID: 29630103 [TBL] [Abstract][Full Text] [Related]
11. LncRNA HIF2PUT inhibited osteosarcoma stem cells proliferation, migration and invasion by regulating HIF2 expression. Zhao D; Wang S; Chu X; Han D Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1342-1348. PubMed ID: 30966832 [TBL] [Abstract][Full Text] [Related]
12. Downregulation of long non-coding RNA MEG3 promotes proliferation, migration, and invasion of human hepatocellular carcinoma cells by upregulating TGF-β1. Dong H; Zhang Y; Xu Y; Ma R; Liu L; Luo C; Jiang W Acta Biochim Biophys Sin (Shanghai); 2019 Jun; 51(6):645-652. PubMed ID: 31089680 [TBL] [Abstract][Full Text] [Related]
13. Silencing of long-non-coding RNA ANCR suppresses the migration and invasion of osteosarcoma cells by activating the p38MAPK signalling pathway. Liu B; Zhao H; Zhang L; Shi X BMC Cancer; 2019 Nov; 19(1):1112. PubMed ID: 31727012 [TBL] [Abstract][Full Text] [Related]
14. LncRNA-p21 inhibited the proliferation of osteosarcoma cells via the miR-130b/PTEN/AKT signaling pathway. Han W; Liu J Biomed Pharmacother; 2018 Jan; 97():911-918. PubMed ID: 29136769 [TBL] [Abstract][Full Text] [Related]
15. Up-regulated lnc-SNHG1 contributes to osteosarcoma progression through sequestration of miR-577 and activation of WNT2B/Wnt/β-catenin pathway. Jiang Z; Jiang C; Fang J Biochem Biophys Res Commun; 2018 Jan; 495(1):238-245. PubMed ID: 29108989 [TBL] [Abstract][Full Text] [Related]
16. A long non-coding RNA contributes to doxorubicin resistance of osteosarcoma. Zhang CL; Zhu KP; Shen GQ; Zhu ZS Tumour Biol; 2016 Feb; 37(2):2737-48. PubMed ID: 26408180 [TBL] [Abstract][Full Text] [Related]
17. Knockdown of CD44 inhibits proliferation, migration and invasion of osteosarcoma cells accompanied by downregulation of cathepsin S. Kong L; Ji H; Gan X; Cao S; Li Z; Jin Y J Orthop Surg Res; 2022 Mar; 17(1):154. PubMed ID: 35264209 [TBL] [Abstract][Full Text] [Related]
18. Decreased expression of long non-coding RNA MEG3 acts as a potential predictor biomarker in progression and poor prognosis of osteosarcoma. Tian ZZ; Guo XJ; Zhao YM; Fang Y Int J Clin Exp Pathol; 2015; 8(11):15138-42. PubMed ID: 26823857 [TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA EPIC1 inhibits viability and invasion of osteosarcoma cells by promoting MEF2D ubiquitylation. Zhao W; Zhang D; Qin P; Zhang J; Cui X; Gao J; Wang J; Li J Int J Biol Macromol; 2019 May; 128():566-573. PubMed ID: 30703420 [TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA PVT1 promotes osteosarcoma development by acting as a molecular sponge to regulate miR-195. Zhou Q; Chen F; Zhao J; Li B; Liang Y; Pan W; Zhang S; Wang X; Zheng D Oncotarget; 2016 Dec; 7(50):82620-82633. PubMed ID: 27813492 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]